SciELO - Scientific Electronic Library Online

 
vol.27 suppl.1Imunologia da Doença por Coronavírus-19 (COVID-19): Uma Perspetiva Para o Clínico, nos Primeiros 4 Meses da Emergência do SARS-CoV-2Reflexões de um Internista e Intensivista em Tempos de Pandemia pelo SARS CoV-2 índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Medicina Interna

versão impressa ISSN 0872-671X

Resumo

SILVA, Cláudio Nunes; CEIA, Filipa  e  TAVARES, Margarida. SARS-CoV-2 Immune Response: An Overview. Medicina Interna [online]. 2020, vol.27, suppl.1, pp.97-104. ISSN 0872-671X.  https://doi.org/10.24950/rspmi/COVID19/CHUSJ/S/2020.

Despite all that is recognized so far on the ongoing SARS-CoV-2 pandemic, many questions remain to be answered, particularly in what concerns pathogen interaction with the human host and whether or not the acquired immune response is protective against reinfection in the long-term. The spectrum of COVID-19 ranges from asymptomatic infections to progressive critical states, a direct upshot from the complex interplay between virus pathogenicity and host antiviral defense. This review focuses on the immunologic response and disarrangements underlying the SARS-CoV-2 pathophysiology, gathering the information not only from the lessons learnt from SARS and MERS-CoV epidemics but also from what is already known about SARS-CoV-2 to date. This knowledge is paramount from the standpoint of disease prevention and control as well as diagnostic pipeline and treatment.

Palavras-chave : Antibodies Neutralizing; Betacoronavirus; Coronavirus Infections/immunology; COVID-19; Immunity Cellular; Pandemics; Betacoronavirus; Immunology; Cell-medianted Immunity; Humoral Immune Response; Innate Immunity; Neutralizing Antibodies.

        · resumo em Português     · texto em Português     · Português ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons